Chicago Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$12.7M |
| 2 |
LSI
Life Storage, Inc.
LSI
|
+$12.5M |
| 3 |
FOCS
Focus Financial Partners Inc. Class A
FOCS
|
+$4.78M |
| 4 |
VECT
VectivBio Holding AG Ordinary Shares
VECT
|
+$2.29M |
| 5 |
GHL
Greenhill & Co., Inc.
GHL
|
+$1.19M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.26% |
| 2 | Real Estate | 18.36% |
| 3 | Financials | 12.73% |
| 4 | Consumer Discretionary | 6.68% |
| 5 | Technology | 0% |
Similar funds
Chicago Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Chicago Capital Management held 27 positions worth $78.1M, down 14% from $91.1M the previous quarter. Its ten largest holdings account for 90% of the portfolio.
Chicago Capital Management withdrew a net $19.7M in Q2 2023, closing 11 positions and reducing 1 holding. Its most notable exit was Oak Street Health, Inc., an estimated $14.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 39% a quarter earlier, followed by Real Estate and Financials.
Against the trend, Chicago Capital Management opened a new position in IVERIC bio, Inc. Common Stock worth $14.1M.
- Chicago Capital Management's largest Q2 2023 buy was IVERIC bio, Inc. Common Stock: 359,561 shares worth $14.1M.
- Chicago Capital Management added most to Focus Financial Partners Inc. Class A in Q2 2023, an estimated $4.78M increase.
- Chicago Capital Management's biggest Q2 2023 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $5.01M.
- Chicago Capital Management fully exited Oak Street Health, Inc. in Q2 2023, selling an estimated $14.7M.
- Chicago Capital Management's ten largest holdings make up 90% of its $78.1M portfolio in Q2 2023.
- Chicago Capital Management opened 4 new positions and closed 11 in Q2 2023.
- Chicago Capital Management's portfolio value fell 14% quarter-over-quarter to $78.1M.
Based on Chicago Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.